{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:49:32Z","timestamp":1779216572303,"version":"3.51.4"},"reference-count":21,"publisher":"American Association for Cancer Research (AACR)","issue":"4","funder":[{"DOI":"10.13039\/100000043","name":"AACR AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH NCI Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Sheikh Khalifa Bin Zayed Al Nahyan Institute"},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP150535"],"award-info":[{"award-number":["RP150535"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>AKT inhibitors have promising activity in AKT1E17K-mutant estrogen receptor (ER)\u2013positive metastatic breast cancer, but the natural history of this rare genomic subtype remains unknown. Utilizing AACR Project GENIE, an international clinicogenomic data-sharing consortium, we conducted a comparative analysis of clinical outcomes of patients with matched AKT1E17K-mutant (n = 153) and AKT1\u2013wild-type (n = 302) metastatic breast cancer. AKT1-mutant cases had similar adjusted overall survival (OS) compared with AKT1\u2013wild-type controls (median OS, 24.1 vs. 29.9, respectively; P = 0.98). AKT1-mutant cases enjoyed longer durations on mTOR inhibitor therapy, an observation previously unrecognized in pivotal clinical trials due to the rarity of this alteration. Other baseline clinicopathologic features, as well as durations on other classes of therapy, were broadly similar. In summary, we demonstrate the feasibility of using a novel and publicly accessible clincogenomic registry to define outcomes in a rare genomically defined cancer subtype, an approach with broad applicability to precision oncology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We delineate the natural history of a rare genomically distinct cancer, AKT1E17K-mutant ER-positive breast cancer, using a publicly accessible registry of real-world patient data, thereby illustrating the potential to inform drug registration through synthetic control data.<\/jats:p>\n                    <jats:p>See related commentary by Castellanos and Baxi, p. 490.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-19-1209","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T22:49:18Z","timestamp":1578696558000},"page":"526-535","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Characteristics and Outcome of\n                    <i>AKT1<\/i>\n                    E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry"],"prefix":"10.1158","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-9285","authenticated-orcid":false,"given":"Lillian M.","family":"Smyth","sequence":"first","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastien","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Yu","sequence":"additional","affiliation":[{"name":"2Princess Margaret Cancer Centre, Toronto, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Lepisto","sequence":"additional","affiliation":[{"name":"3Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-1251","authenticated-orcid":false,"given":"Monica","family":"Arnedos","sequence":"additional","affiliation":[{"name":"4Institut Gustave Roussy, Villejuif, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Hasset","sequence":"additional","affiliation":[{"name":"3Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele L.","family":"Lenoue-Newton","sequence":"additional","affiliation":[{"name":"5Vanderbilt Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Blauvelt","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semih","family":"Dogan","sequence":"additional","affiliation":[{"name":"4Institut Gustave Roussy, Villejuif, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-9039","authenticated-orcid":false,"given":"Christine M.","family":"Micheel","sequence":"additional","affiliation":[{"name":"5Vanderbilt Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetna","family":"Wathoo","sequence":"additional","affiliation":[{"name":"6The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-8828","authenticated-orcid":false,"given":"Hugo","family":"Horlings","sequence":"additional","affiliation":[{"name":"7Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hudecek","sequence":"additional","affiliation":[{"name":"7Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin E.","family":"Gross","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-2859","authenticated-orcid":false,"given":"Ritika","family":"Kundra","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4269-6566","authenticated-orcid":false,"given":"Shawn M.","family":"Sweeney","sequence":"additional","affiliation":[{"name":"8American Association for Cancer Research, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JianJiong","family":"Gao","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Zarski","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M.","family":"Gardos","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Lee","sequence":"additional","affiliation":[{"name":"8American Association for Cancer Research, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Sheffler-Collins","sequence":"additional","affiliation":[{"name":"8American Association for Cancer Research, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben H.","family":"Park","sequence":"additional","affiliation":[{"name":"5Vanderbilt Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4955-6475","authenticated-orcid":false,"given":"Charles L.","family":"Sawyers","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"4Institut Gustave Roussy, Villejuif, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-2730","authenticated-orcid":false,"given":"Mia","family":"Levy","sequence":"additional","affiliation":[{"name":"5Vanderbilt Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[{"name":"6The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-2999","authenticated-orcid":false,"given":"Philippe L.","family":"Bedard","sequence":"additional","affiliation":[{"name":"2Princess Margaret Cancer Centre, Toronto, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Schrag","sequence":"additional","affiliation":[{"name":"3Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Hyman","sequence":"additional","affiliation":[{"name":"1Memorial Sloan Kettering Cancer Center, New York, New York."},{"name":"8American Association for Cancer Research, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2022060622163530800_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"key":"2022060622163530800_bib2","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N Engl J Med"},{"key":"2022060622163530800_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"2022060622163530800_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.bjc.6604212","article-title":"Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias","volume":"98","author":"Kim","year":"2008","journal-title":"Br J Cancer"},{"key":"2022060622163530800_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"2022060622163530800_bib6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2017.73.0143","article-title":"AKT inhibition in solid tumors with AKT1 mutations","volume":"35","author":"Hyman","year":"2017","journal-title":"J Clin Oncol"},{"key":"2022060622163530800_bib7","article-title":"AZD5363 in combination with fulvestrant in AKT1-mutant ER-positive metastatic breast cancer","author":"Smyth","year":"2018","journal-title":"American Association for Cancer Research Annual Meeting"},{"key":"2022060622163530800_bib8","doi-asserted-by":"crossref","first-page":"OF7","DOI":"10.1158\/2159-8290.CD-NB2018-153","article-title":"Capivasertib active against AKT1-mutated cancers","volume":"9","year":"2019","journal-title":"Cancer Discov"},{"key":"2022060622163530800_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"AACR Project GENIE Consortium","year":"2017","journal-title":"Cancer Discov"},{"key":"2022060622163530800_bib10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic characterization of primary invasive lobular breast cancer","volume":"34","author":"Desmedt","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022060622163530800_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.aaw9032","article-title":"Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3K\u03b1 inhibitors","volume":"366","author":"Vasan","year":"2019","journal-title":"Science"},{"key":"2022060622163530800_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2014.60.1971","article-title":"Correlative analysis of genetic alterations and everolimus benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: results from BOLERO-2","volume":"34","author":"Hortobagyi","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022060622163530800_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jama.2019.3241","article-title":"Association of patient characteristics and tumor genomics with clinical outcomes among patients with non-small cell lung cancer using a clinicogenomic database","volume":"321","author":"Singal","year":"2019","journal-title":"JAMA"},{"key":"2022060622163530800_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","article-title":"Implementing genome-driven oncology","volume":"168","author":"Hyman","year":"2017","journal-title":"Cell"},{"key":"2022060622163530800_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-med-062016-050343","article-title":"Basket studies: redefining clinical trials in the era of genome-driven oncology","volume":"69","author":"Tao","year":"2018","journal-title":"Annu Rev Med"},{"key":"2022060622163530800_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2019.37.15_suppl.1055","article-title":"Real-world evidence of male breast cancer (BC) patients treated with palbociclib (PAL) in combination with endocrine therapy (ET)","volume":"37","author":"Bartlett","year":"2019","journal-title":"J Clin Oncol"},{"key":"2022060622163530800_bib17","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2022060622163530800_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2022060622163530800_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/b97377","volume-title":"Survival analysis: Techniques for censored and truncated data","author":"Klein","year":"2003"},{"key":"2022060622163530800_bib20","article-title":"OncoKB: a pre","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2022060622163530800_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/10\/4\/526\/1816909\/526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/10\/4\/526\/1816909\/526.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T18:17:13Z","timestamp":1654539433000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/10\/4\/526\/2419\/Characteristics-and-Outcome-of-AKT1E17K-Mutant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-19-1209","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.6547928","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6547928.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.22535717","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22535717.v1","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}